Catalent (CTLT) Tops Q4 EPS by 8c, FY Revenue Guidance Beats
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
- After-Hours Movers: WDC, BE, DECK, FIX, RNG
Catalent, Inc. Reports Fourth Quarter and Full Year 2017 Results
August 28, 2017 4:15 PM EDTQ4'17 revenue $616.9 million increased 16% as-reported, or 19% in constant currency from the prior-year period. FY'17 revenue $2,075.4 million increased 12% as-reported, or 15% in constant currency from the prior-year period. Entered into an exclusive long-term supply agreement to produce the next generation of Pfizer's leading OTC pain relief product with the launch of new Advil Liqui-Gels Minis. Increased spray drying and roller compaction capacity at our San Diego, California facility in response to market demand for solubility enhancement solutions.... More



